Search Results

Agricola

Record details

Synergistic integration of deep learning with protein docking in cardiovascular disease treatment strategies.

• Authors : Yakoubi S; Faculty of Life and Environmental Sciences, University of Tsukuba, Ibaraki, Japan.; Alliance for Research on the Mediterranean North Africa (ARENA), University of Tsukuba, Ibaraki, Japan.

Subjects: Molecular Docking Simulation* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/metabolism

• Source: IUBMB life [IUBMB Life] 2024 Sep; Vol. 76 (9), pp. 666-696. Date of Electronic Publication: 2024 May 15.Publisher: Published for the International Union of Biochemistry and Molecular Biology by Taylor & Francis Country of Publication: England NLM ID: 100888706

Record details

Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.

• Authors : Gu Y; School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.; Du L

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Drug Delivery Systems*/Drug Delivery Systems*/Drug Delivery Systems*/methods; Humans

• Source: Biomolecules [Biomolecules] 2024 Aug 07; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment.

• Authors : Guo C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China; Department of Pulmonary and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Key Laboratory of Sichuan Province & Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Subjects: Cytochrome P-450 CYP11B2*/Cytochrome P-450 CYP11B2*/Cytochrome P-450 CYP11B2*/antagonists & inhibitors ; Cytochrome P-450 CYP11B2*/Cytochrome P-450 CYP11B2*/Cytochrome P-450 CYP11B2*/metabolism ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy

• Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Aug 05; Vol. 274, pp. 116521. Date of Electronic Publication: 2024 May 21.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Annamalai University Files Patent Application for Process and Synthesis of Nanoliposomes and Indirubbin Combination for Cardiovascular Disease Treatment.

• Source: Indian Patent News. 2024.

Record details

Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis.

• Authors : Udriște AS; Department 4 Cardio-Thoracic Pathology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Burdușel AC

• Source: Polymers [Polymers (Basel)] 2024 May 16; Vol. 16 (10). Date of Electronic Publication: 2024 May 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101545357 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4360

Record details

The Role of Coenzyme Q10 in Cardiovascular Disease Treatment: An Updated 2024 Systematic Review and Meta-Analysis of Prospective Cohort Studies (1990-2024) (Updated July 16, 2024).

• Source: Health & Medicine Week. 2024, pages. 6726

Record details

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States.

• Authors : Tajeu GS; Department of Health Services Administration and Policy, Temple University, Philadelphia, PA (G.S.T.).; Ruiz-Negrón N

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/diagnosis ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/therapy

• Source: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2024 Mar; Vol. 17 (3), pp. e009999. Date of Electronic Publication: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148 Publication Model: Print-Electronic Cited Medium:

Record details

A Smooth Muscle Cell-Based Ferroptosis Model to Evaluate Iron-Chelating Molecules for Cardiovascular Disease Treatment.

• Authors : El Hajj S; Université de Lorraine, CITHEFOR, F-54505 Vandoeuvre Les Nancy, France.; Université de Lorraine, LRGP, CNRS, F-54000 Nancy, France.

• Source: Current issues in molecular biology [Curr Issues Mol Biol] 2024 Feb 04; Vol. 46 (2), pp. 1348-1359. Date of Electronic Publication: 2024 Feb 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100931761 Publication Model: Electronic Cited Medium: Internet ISSN: 1467-3045

Record details

Elixir Medical to Announce Data from Three Platforms Designed to Transform Cardiovascular Disease Treatment at EuroPCR 2024, Including Two Late-Breakers

• Source: ENP Newswire. May 1, 2024

Record details